The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Is docetaxel-prednisone (DP) feasible in frail elderly (age 75 or older) patients with castration-resistant metastatic prostate cancer (CRMPC)? GERICO10-GETUG P03 trial: A trial from elderly and genitourinary oncology UNICANCER groups.
Loic Mourey
No relevant relationships to disclose
Emmanuel Sevin
No relevant relationships to disclose
Igor Latorzeff
No relevant relationships to disclose
Nadine Houede
No relevant relationships to disclose
Jérome Meunier
No relevant relationships to disclose
Frank Priou
No relevant relationships to disclose
Gwenaelle Gravis
No relevant relationships to disclose
Elisabeth Carola
No relevant relationships to disclose
Christine Orsini
No relevant relationships to disclose
Thomas Filleron
No relevant relationships to disclose